LawCite Search |
LawCite Markup Tool |
Help |
Feedback
Law Cite |
Case Name | Citation(s) | Court | Jurisdiction | Date | Full Text | Citation Index † | |
Regents of the University of California & Regeneron, Inc | [2016] APO 33 | IP Australia - Australian Patent Office | Australia | 10 Jun 2016 | AustLII |
|
|
Pharma Mar SA | [2020] APO 8 | IP Australia - Australian Patent Office | Australia | 31 Jan 2020 | AustLII |
|
|
Aventis Pharma SA | [2016] APO 34 | IP Australia - Australian Patent Office | Australia | 10 Jun 2016 | AustLII |
|
|
Banki Haddock Fiora v Glaxo Group Ltd | [2024] APO 20 | IP Australia - Australian Patent Office | Australia | 28 May 2024 | AustLII |
|
Legislation Name | Provision |
Patents Act (Cth) | s70, s74 |
Therapeutic Goods Act 1989 (Cth) | s3, s9A |
Case Name | Citation(s) | Court | Jurisdiction | Date | Full Text | Citation Index † | |
Pharmacia Italia SpA v Mayne Pharma Pty Ltd |
[2006] FCA 305; |
Federal Court of Australia | Australia - Commonwealth | 29 Mar 2006 | AustLII |
|
|
Celgene Corporation |
[2011] APO 37; |
IP Australia - Australian Patent Office | Australia | 3 Jun 2011 | AustLII |
|
|
KG |
[2002] APO 12; |
IP Australia - Australian Patent Office | Australia | 11 Apr 2002 | AustLII |
|
|
Regents of the University of California & Regeneron, Inc | [2016] APO 33 | IP Australia - Australian Patent Office | Australia | 10 Jun 2016 | AustLII |
|
|
Pharma Mar SA | [2020] APO 8 | IP Australia - Australian Patent Office | Australia | 31 Jan 2020 | AustLII |
|
|
Aventis Pharma SA | [2016] APO 34 | IP Australia - Australian Patent Office | Australia | 10 Jun 2016 | AustLII |
|
|
Banki Haddock Fiora v Glaxo Group Ltd | [2024] APO 20 | IP Australia - Australian Patent Office | Australia | 28 May 2024 | AustLII |
|